Arcellx pulls in $115m Series C
Arcellx, a clinical-stage biopharmaceutical company, has raised $115 million in Series C financing.
Arcellx, a clinical-stage biopharmaceutical company, has raised $115 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination